Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water

Toxicology and Applied Pharmacology

Volumn 141, Issue 1, 1996, Pages 145-158

  Kerger, B D ^a   Paustenbach, D J ^a   Corbett, G E ^a   Finley, B L ^a  

^a CARDNO CHEMRISK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; CHROMIUM CHLORIDE; DICHROMATE POTASSIUM;

ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG COMPARISON; EXPOSURE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; URINARY EXCRETION; WATER QUALITY;

ANIMALIA;

EID: 0030296898     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0271     Document Type: Article

References (52)

1. Aitio, A., Javisalo, J., Kiilunen, M., Kalliomaki, P. L., and Kalliomaki, K. (1988). Chromium. In Biological Monitoring of Toxic Metals (T. W. Clarkson, L. Friberg, G. F. Nordberg, and D. R. Sager, Eds.), pp. 369-382. Plenum, New York.
2. Anderson, R. A. (1994). Nutritional and toxicologic aspects of chromium intake: An overview. In Risk Assessment of Essential Elements (W. Mertz, C. O. Abernathy, and S. S. Olin, Eds.), pp. 187-195. International Life Sciences Institute, Washington, DC.
3. Anderson, R. A., Bryden, N. A., and Polansky, M. M. (1996). Lack of toxicity of chromium chloride and chromium picolinate. Fundam. Appl. Toxicol. 30, 299. [Abstract]
4. Anwar, R. A., Langham, F. F., and Hoppert, C. A. (1961). Chronic toxicity studies, 3: Chronic toxicity of cadmium and chromium in dogs. Arch. Environ. 3, 456-460.
5. Borneff, J., Engelhardt, K., Griem, W., Kunte, H., and Reichert, J. (1968). Kanzerogene Substanzen in wasser und boden (German). Arch. Hyg. Bakteriol. 152 (1), 45-53.
6. Capellmann, M., and Bolt, H. M. (1992). Chromium(VI) reducing capacity of ascorbic acid and of human plasma in vitro. Arch. Toxicol. 66, 45-50.
7. Chute, S. M., Overman, S. K., Kerger, B. D., Finley, B. L., and Paustenbach, D. J. (1996). The Cr(VI) reductive capacity of household beverages: Implications for risk assessment. Fundam. Appl. Toxicol. 30, 7. [Abstract]
8. Coogan, T., Squibb, K. S., Motz, J., Kinney, P. L., and Costa, M. (1991). Distribution of chromium within cells of the blood. Toxicol. Appl. Pharmacol. 108, 157-166.
9. De Flora, S. (1996). Letter to author. January.
10. De Flora, S., Badolati, G. S., Serra, D., Picciotto, A., Magnolia, M. R., and Savarino, V. (1987). Circadian reduction of chromium in the gastric environment. Mutat. Res. 192, 169-174.
11. De Flora, S., Serra, D., Camoirano, A., and Zanacch, P. (1989). Metabolic reduction of chromium as related to its carcinogenic properties. Biol. Trace Elem. Res. 21, 179-187.
12. De Flora, S., and Wetterhahn, K. E. (1989). Mechanisms of chromium metabolism and genotoxicity. Life Chem. Rep. 7, 169-244.
13. Donaldson, R. M., Jr., and Barreras, R. F. (1966). Intestinal absorption of trace quantities of chromium. J. Lab. Clin. Med. 68, 484-493.
14. Edel, J., and Sabbioni, E. (1985). Pathways of Cr(III) and Cr(VI) in the rat after intratracheal administration. Hum. Toxicol. 4, 409-416.
15. Finley, B. L., Scott, P. K., Norton, R. L., Gargas, M. L., and Paustenbach, D. J. (1996). Urinary chromium concentrations in humans following ingestion of safe doses of hexavalent and trivalent chromium: Implications for biomonitoring. Submitted for publication.
16. Gargas, M. L., Norton, R. L., Paustenbach, D. J., and Finley, B. L. (1994). Urinary excretion of chromium by humans following ingestion of chromium picolinate: Implications for biomonitoring. Drug. Metab. Dispos. 22, 522-529.
17. Gonzalez-Vergara, E., De Gonzalez, B. C., Hegenauer, J., and Saltman, P. (1981). Chromium coordination compounds of pyridoxal and nicotinic acid: synthesis, absorption and metabolism. Israel J. Chem. 21, 18-22.
18. Gray, S. J., and Sterling, K. (1950). The tagging of red cells and plasma proteins with radioactive chromium. J. Clin. Invest. 29, 1604-1613.
19. Gross, W. G., and Heller, V. G. (1946). Chromates in animal nutrition. J. Ind. Hyg. Toxicol. 28, 52-56.
20. Gylseth, B., Gundersen, N., and Langard, S. (1977). Evaluation of chromium exposure based on a simplified method for urinary chromium determination. Scand. J. Work Environ. Health 3, 28-31.
21. Kerger, B. D., Finley, B. L., Corbett, G. E., Dodge, D. G., and Paustenbach, D. J. (1996a). Ingestion of chromium (VI) in drinking water by human volunteers: Absorption, distribution and excretion of single and repeated doses. J. Toxicol. Environ. Health, in press.
22. Kerger, B. D., Richter, R. O., Chute, S. M., Dodge, D. G., Overman, S. K., Liang, J., Finley, B. L., and Paustenbach, D. J. (1996b). Refined exposure assessment for ingestion of tapwater contaminated with hexavalent chromium: Consideration of exogenous and endogenous reducing agents. J. Exp. Anal. Environ. Epidemiol. 6, 163-179.
23. Korallus, U. (1986a). Biological activity of chromium(VI)-against chromium (III)-compounds: New aspects of biological monitoring. In Chromium Symposium 1986: An Update, May 20-21. Arlington, VA. [Abstract]
24. Korallus, U. (1986b). Chromium compounds: Occupational health, toxicological and biological monitoring aspects. Toxicol. Environ. Chem. 12, 47-59.
25. Korallus, U., Harzdorf, C., and Lewalter, J. (1984). Experimental bases for ascorbic acid therapy of poisoning by hexavalent chromium compounds. Int. Arch. Occup. Environ. Health 53, 247-256.
26. Kortenkamp, A., and Beyersmann, D. (1987). Uptake of chromium(III) complexes by erythrocytes. Toxicol. Environ. Chem. 14, 23-32.
27. Langard, S., Gundersen, N., Tsalev, D. L., and Gylseth, B. (1978). Whole blood chromium level and chromium excretion in the rat after zinc chromate inhalation. Acta Pharmacol. Toxicol. 42, 142-149.
28. Levis, A. G., Bianchi, V., Tamino, G., and Pegoraro, B. (1978). Cytotoxic effects of hexavalent and trivalent chromium on mammalian cells in vitro. Br. J. Cancer 37, 386-396.
29. Lewalter, J., Korallus, U., Harzdorf, C., and Weidemann, H. (1985). Chromium bond detection in isolated erythrocytes: A new principle of biological monitoring of exposure to hexavalent chromium. Int. Arch. Occup. Environ. Health 55, 305-318.
30. Lim, T. H., Sargent, T., III, and Kusubov, N. (1983). Kinetics of trace element chromium(III) in the body. Am. J. Physiol. 244 (4), R445-R454.
31. Lindberg, E., and Vesterberg, O. (1983a). Monitoring exposure to chromic acid in chromeplating by measuring chromium in urine. Scand. J. Work Environ. Health 9, 333-340.
32. Lindberg, E., and Vesterberg, O. (1983b). Urinary excretion of proteins in chromeplaters, exchromeplaters and referents. Scand. J. Work Environ. Health 9, 505-510.
33. MacKenzie, R., Byerrum, U., Decker, C., Hoppert, C., and Langham, F. (1958). Chronic toxicity studies: Hexavalent and trivalent chromium administered in drinking water. Arch. Ind. Health 18, 232-234.
34. Mertz, W. (1969). Chromium occurrence and function in biological systems. Physiol. Rev. 49, 163-239.
35. Mertz, W. (1975). Effects and metabolism of glucose tolerance factor. Nutr. Rev. 33(5), 129-135.
36. Mertz, W., and Roginski, E. E. (1971). Chromium metabolism: The glucose tolerance factor. In Newer Trace Elements in Nutrition (W. Mertz and W. E. Cornatzer, Eds.). Dekker, New York.
37. Miksche, L., Lewalter, J., and Korallus, U. (1994). Determination of chromium in erythrocytes: A new principle for biological monitoring in chromium (VI) exposed workers. In Proceedings of the DOE Symposium on Biomarkers. February, San Diego, CA.
38. Minoia, C., and Cavalleri, A. (1988). Chromium in urine, serum and red blood cells in the biological monitoring of workers exposed to different chromium valency states. Sci. Total Environ. 71, 323-327.
39. Mutti, A., Pedroni, C., Arfini, G., Franchini, I., Minoia, C., Micoli, G., and Baldi, C. (1985). Biological monitoring of occupational exposure to different chromium compounds at various valency states. In Carcinogenic and Mutagenic Metal Compounds Environmental and Analytical Chemistry and Biological Effects (M. E., R. W. Frei, W. Hardi, and C. Schlatter, Eds.), pp. 119-125. Gordon & Breach, London.
40. O'Flaherty, E. (1993). A pharmacokinetic model for chromium. Toxicol. Lett. 68, 145-158.
41. O'Flaherty, E. (1994). Comparison of reference dose with estimated safe and adequate daily dietary intake from chromium. In Risk Assessment of Essential Elements (W. Mertz, C. O. Abernathy, and S. S. Olin, Eds.). ILSI Press, Washington, DC.
42. Ottenwaelder, H., and Wiegand, H. J. (1988). Uptake of 51Cr(VI) by human erythrocytes: Evidence for a carrier-mediated transport mechanism. Sci. Total Environ. 71, 561-566.
43. Paustenbach, D. J., Throop, L., Fritch, D., McDougal, M., Overman, S. K., and Kerger, B. D. (1996). Validation of a rapid assessment method for measuring total chromium in human blood. In review.
44. Petrilli, F. L., and De Flora, S. (1988). Metabolic reduction of chromium as a threshold mechanism limiting its in-vivo activity. Sci. Total Environ. 71(3), 357-364.
45. 51Cr from labelled leukocytes - A new theory. Blood 33(3), 408-413.
46. Sanderson, C. J. (1976). The uptake and retention of chromium by cells. Transplantation 21, 526-529.
47. 14C-ascorbate in guinea pigs. Biol. Trace Elem. Res. 41, 279-294.
48. Sipes, J. G., and Gandolfi, A. J. (1991). Biotransformation of toxicants. In Casarett and Doull's Toxicology: The Basic Science of Poisons (M. O. Amdur, J. Doull, and C. D. Klassen, Eds.). Pergamon, New York.
49. USEPA (1991). National primary drinking water regulations-synthetic organic chemicals and inorganic chemicals; monitoring for unregulated contaminants; national primary drinking water regulations implementation; national secondary drinking water regulations. Fed. Regist. 56, 3526-3597.
50. USEPA (1996). Chromium. Washington, D.C.: Integrated Risk Information System (IRIS). Office of Health and Environmental Assessment, U.S. Environmental Protection Agency. Down-loaded from National Library of Medicine on-line service, January 25.
51. Weber, H. (1983). Long-term study of the distribution of soluble chromate-51 in the rat after a single intratracheal administration. J. Toxicol. Environ. Health 11, 749-764.
52. Wiegand, H. J., Ottenwalder, H., and Bolt, H. M. (1988). Recent advances in biological monitoring of hexavalent chromium compounds. Sci. Total Environ. 71, 309-315.